Indicators of the screening program for congenital hypothyroidism in alexandria

Nihad I Dabbous1, Hanan M Abd El-Aziz, Nagwa Y Abou El-Enein

  • 1Department of Family Health, High Institute of Public Health, Alexandria, Egypt. hnnmourad@yahoo.com.

Insights

Newborn screening for congenital hypothyroidism (CH) shows increasing coverage and effectiveness in Alexandria. The program improved case detection and management over three years.

Area of Science:

  • Pediatric Endocrinology
  • Public Health Screening Programs

Background:

  • Newborn screening for metabolic and endocrinological disorders is a critical public health service.
  • Congenital hypothyroidism (CH) is a treatable condition detectable through newborn screening.

Purpose of the Study:

  • To evaluate the Alexandria congenital hypothyroidism (CH) screening program's coverage.
  • To assess the program's effectiveness in case detection and management.
  • To determine the positive predictive value of the CH screening test.

Main Methods:

  • A retrospective record review was conducted from October 2000 to December 2003.
  • Data analysis included program coverage, true/false positives, and positive predictive value.
  • A follow-up study of positive CH cases was performed in 2002.

Main Results:

  • Program coverage increased from 49.4% in 2001 to 77.6% in 2003.
  • Positive predictive values ranged from 57% to 65% across the study years.
  • Therapy compliance was 73.3%, with 56.7% adhering to fixed schedules.

Conclusions:

  • The Alexandria CH screening program demonstrated a positive trend in coverage and effectiveness.
  • Improvements in detection and management were observed over the study period.
  • The study highlights the importance of ongoing evaluation for optimizing newborn screening programs.

Related Concept Videos

Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...